GlassScriptPhysician profile
Silas S Luna
NPI 1003395872
$1,722.17
in general payments reported to CMS, 2019-2025
17 companies · $606 in 2025
The $606 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $476 · 2022: $304 · 2023: $244 · 2024: $92.27 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $942.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $353.78 | 2021-2023 | Myrbetriq |
| Sumitomo Pharma America, INC. | $333.02 | 2023-2025 | Gemtesa, Orgovyx |
| Calyxo, INC. | $241.41 | 2023-2025 | Cvac Aspiration System |
| Abbvie INC. | $130.39 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $104.64 | 2022-2025 | Keytruda, Lynparza |
| Procept Biorobotics Corporation | $99.40 | 2022 | |
| Urogen Pharma, INC. | $72.63 | 2022-2025 | |
| Blue Earth Diagnostics | $59.24 | 2021-2022 | |
| Olympus America INC. | $57.16 | 2025 | Itind System |
| 180 Medical, INC. | $56.99 | 2022-2025 | Self Cath |
| Boston Scientific Corporation | $50.23 | 2023-2024 | |
| Axonics, INC. | $46.79 | 2021-2024 | Axonics |
| Urovant Sciences INC | $34.22 | 2022 | |
| Teleflex LLC | $26.45 | 2021 | |
| Progenics Pharmaceuticals, INC. | $19.65 | 2023 | Pylarify |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $19.21 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $16.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Silas Luna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.